$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 11 12 13 14 15 16 17 18 19 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 6,650 | 34,913 | 16,000 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.45 | 555 | 32,995 | 34,199 | 34.8 K to 34.2 K (-1.60 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.40 | 494 | 29,344 | 34,754 | 35.2 K to 34.8 K (-1.40 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.18 | 895 | 52,966 | 35,248 | 36.1 K to 35.2 K (-2.48 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.16 | 308 | 18,221 | 36,143 | 36.5 K to 36.1 K (-0.84 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.12 | 2,498 | 147,682 | 36,451 | 38.9 K to 36.5 K (-6.41 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.02 | 771 | 45,504 | 38,949 | 39.7 K to 38.9 K (-1.94 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.01 | 31 | 1,829 | 39,720 | 39.8 K to 39.7 K (-0.08 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.00 | 913 | 53,867 | 39,751 | 40.7 K to 39.8 K (-2.25 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.99 | 62 | 3,657 | 40,664 | 40.7 K to 40.7 K (-0.15 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.98 | 123 | 7,255 | 40,726 | 40.8 K to 40.7 K (-0.30 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 5.25 | 6,650 | 34,913 | 40,849 | 34.2 K to 40.8 K (+19.45 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 467 | 10,064 | 4,195 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.45 | 39 | 2,319 | 0 | 39 to 0 (-100.00 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.40 | 35 | 2,079 | 39 | 74 to 39 (-47.30 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.18 | 60 | 3,551 | 74 | 134 to 74 (-44.78 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.16 | 25 | 1,479 | 134 | 159 to 134 (-15.72 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.12 | 174 | 10,287 | 159 | 333 to 159 (-52.25 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.02 | 55 | 3,246 | 333 | 388 to 333 (-14.18 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.01 | 2 | 118 | 388 | 390 to 388 (-0.51 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 59.00 | 64 | 3,776 | 390 | 454 to 390 (-14.10 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 58.99 | 4 | 236 | 454 | 458 to 454 (-0.87 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 58.98 | 9 | 531 | 458 | 467 to 458 (-1.93 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 21.55 | 467 | 10,064 | 467 | 0 to 467 |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 3.63 | 10,000 | 36,250 | 0 | |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 58.27 | 3,000 | 174,810 | 22,890 | 25.9 K to 22.9 K (-11.59 %) |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 58.25 | 2,100 | 122,325 | 25,890 | 28 K to 25.9 K (-7.50 %) |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 58.16 | 100 | 5,816 | 27,990 | 28.1 K to 28 K (-0.36 %) |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 58.15 | 1,200 | 69,780 | 28,090 | 29.3 K to 28.1 K (-4.10 %) |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 58.13 | 100 | 5,813 | 29,290 | 29.4 K to 29.3 K (-0.34 %) |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 58.10 | 3,500 | 203,350 | 29,390 | 32.9 K to 29.4 K (-10.64 %) |
Aug 20 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 3.63 | 10,000 | 36,250 | 32,890 | 22.9 K to 32.9 K (+43.69 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 50,000 | 1,192,500 | 90,800 | |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.77 | 400 | 22,308 | 9,570 | 10 K to 9.6 K (-4.01 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.76 | 800 | 44,608 | 9,970 | 10.8 K to 10 K (-7.43 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.75 | 400 | 22,300 | 10,770 | 11.2 K to 10.8 K (-3.58 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.73 | 400 | 22,292 | 11,170 | 11.6 K to 11.2 K (-3.46 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.72 | 400 | 22,288 | 11,570 | 12 K to 11.6 K (-3.34 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.71 | 600 | 33,426 | 11,970 | 12.6 K to 12 K (-4.77 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.70 | 11,300 | 629,410 | 12,570 | 23.9 K to 12.6 K (-47.34 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.65 | 200 | 11,130 | 23,870 | 24.1 K to 23.9 K (-0.83 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.55 | 100 | 5,555 | 24,070 | 24.2 K to 24.1 K (-0.41 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.51 | 5,000 | 277,550 | 24,170 | 29.2 K to 24.2 K (-17.14 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.50 | 5,000 | 277,500 | 29,170 | 34.2 K to 29.2 K (-14.63 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.46 | 2,015 | 111,752 | 34,170 | 36.2 K to 34.2 K (-5.57 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.30 | 200 | 11,060 | 36,185 | 36.4 K to 36.2 K (-0.55 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.29 | 100 | 5,529 | 36,385 | 36.5 K to 36.4 K (-0.27 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.28 | 800 | 44,224 | 36,485 | 37.3 K to 36.5 K (-2.15 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 55.25 | 16,000 | 884,000 | 37,285 | 53.3 K to 37.3 K (-30.03 %) |
Aug 17 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 50,000 | 1,192,500 | 53,285 | 3.3 K to 53.3 K (+1,522.07 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Option Exercise | M | 36.13 | 3,460 | 124,993 | 6,540 | |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Option Exercise | M | 15.02 | 3,540 | 53,171 | 3,960 | |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 55.40 | 700 | 38,780 | 3,555 | 4.3 K to 3.6 K (-16.45 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 55.12 | 100 | 5,512 | 4,255 | 4.4 K to 4.3 K (-2.30 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 55.06 | 300 | 16,518 | 4,355 | 4.7 K to 4.4 K (-6.44 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 55.04 | 100 | 5,504 | 4,655 | 4.8 K to 4.7 K (-2.10 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 55.01 | 1,100 | 60,511 | 4,755 | 5.9 K to 4.8 K (-18.79 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 55.00 | 2,300 | 126,500 | 5,855 | 8.2 K to 5.9 K (-28.20 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 54.90 | 900 | 49,410 | 8,155 | 9.1 K to 8.2 K (-9.94 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 54.85 | 200 | 10,970 | 9,055 | 9.3 K to 9.1 K (-2.16 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 54.84 | 100 | 5,484 | 9,255 | 9.4 K to 9.3 K (-1.07 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 54.82 | 400 | 21,928 | 9,355 | 9.8 K to 9.4 K (-4.10 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 54.81 | 300 | 16,443 | 9,755 | 10.1 K to 9.8 K (-2.98 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 54.80 | 500 | 27,400 | 10,055 | 10.6 K to 10.1 K (-4.74 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Buy | M | 36.13 | 3,460 | 124,993 | 10,555 | 7.1 K to 10.6 K (+48.77 %) |
Aug 16 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Buy | M | 15.02 | 3,540 | 53,171 | 7,095 | 3.6 K to 7.1 K (+99.58 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 30.74 | 1,423 | 43,743 | 20,498 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 577 | 12,434 | 5,762 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.61 | 173 | 10,140 | 0 | 173 to 0 (-100.00 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.52 | 26 | 1,522 | 173 | 199 to 173 (-13.07 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.50 | 199 | 11,642 | 199 | 398 to 199 (-50.00 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.33 | 487 | 28,407 | 398 | 885 to 398 (-55.03 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.24 | 17 | 990 | 885 | 902 to 885 (-1.88 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.23 | 26 | 1,514 | 902 | 928 to 902 (-2.80 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.22 | 17 | 990 | 928 | 945 to 928 (-1.80 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.21 | 9 | 524 | 945 | 954 to 945 (-0.94 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.20 | 303 | 17,635 | 954 | 1.3 K to 954 (-24.11 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.17 | 9 | 524 | 1,257 | 1.3 K to 1.3 K (-0.71 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.16 | 43 | 2,501 | 1,266 | 1.3 K to 1.3 K (-3.28 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.14 | 17 | 988 | 1,309 | 1.3 K to 1.3 K (-1.28 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.12 | 9 | 523 | 1,326 | 1.3 K to 1.3 K (-0.67 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.10 | 94 | 5,461 | 1,335 | 1.4 K to 1.3 K (-6.58 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 57.82 | 17 | 983 | 1,429 | 1.4 K to 1.4 K (-1.18 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 57.81 | 104 | 6,012 | 1,446 | 1.6 K to 1.4 K (-6.71 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 57.80 | 9 | 520 | 1,550 | 1.6 K to 1.6 K (-0.58 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 57.76 | 17 | 982 | 1,559 | 1.6 K to 1.6 K (-1.08 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 57.75 | 424 | 24,486 | 1,576 | 2 K to 1.6 K (-21.20 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 30.74 | 1,423 | 43,743 | 2,000 | 577 to 2 K (+246.62 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 577 | 12,434 | 577 | 0 to 577 |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 345 | 2,447 | 16,655 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,405 | 21,645 | 0 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.61 | 238 | 13,949 | 4,766 | 5 K to 4.8 K (-4.76 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.52 | 36 | 2,107 | 5,004 | 5 K to 5 K (-0.71 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.50 | 273 | 15,971 | 5,040 | 5.3 K to 5 K (-5.14 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.33 | 670 | 39,081 | 5,313 | 6 K to 5.3 K (-11.20 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.24 | 24 | 1,398 | 5,983 | 6 K to 6 K (-0.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.23 | 36 | 2,096 | 6,007 | 6 K to 6 K (-0.60 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.22 | 24 | 1,397 | 6,043 | 6.1 K to 6 K (-0.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.21 | 12 | 699 | 6,067 | 6.1 K to 6.1 K (-0.20 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.20 | 416 | 24,211 | 6,079 | 6.5 K to 6.1 K (-6.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.17 | 12 | 698 | 6,495 | 6.5 K to 6.5 K (-0.18 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.16 | 60 | 3,490 | 6,507 | 6.6 K to 6.5 K (-0.91 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.14 | 21 | 1,221 | 6,567 | 6.6 K to 6.6 K (-0.32 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.12 | 12 | 697 | 6,588 | 6.6 K to 6.6 K (-0.18 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.10 | 131 | 7,611 | 6,600 | 6.7 K to 6.6 K (-1.95 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.82 | 24 | 1,388 | 6,731 | 6.8 K to 6.7 K (-0.36 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.81 | 143 | 8,267 | 6,755 | 6.9 K to 6.8 K (-2.07 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.80 | 12 | 694 | 6,898 | 6.9 K to 6.9 K (-0.17 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.76 | 24 | 1,386 | 6,910 | 6.9 K to 6.9 K (-0.35 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.75 | 582 | 33,611 | 6,934 | 7.5 K to 6.9 K (-7.74 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 345 | 2,447 | 7,516 | 7.2 K to 7.5 K (+4.81 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,405 | 21,645 | 7,171 | 4.8 K to 7.2 K (+50.46 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,450 | 24,379 | 36,950 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.61 | 125 | 7,326 | 2,890 | 3 K to 2.9 K (-4.15 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.52 | 19 | 1,112 | 3,015 | 3 K to 3 K (-0.63 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.50 | 144 | 8,424 | 3,034 | 3.2 K to 3 K (-4.53 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.33 | 353 | 20,590 | 3,178 | 3.5 K to 3.2 K (-10.00 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.24 | 13 | 757 | 3,531 | 3.5 K to 3.5 K (-0.37 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.23 | 19 | 1,106 | 3,544 | 3.6 K to 3.5 K (-0.53 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.22 | 13 | 757 | 3,563 | 3.6 K to 3.6 K (-0.36 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.21 | 6 | 349 | 3,576 | 3.6 K to 3.6 K (-0.17 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.20 | 219 | 12,746 | 3,582 | 3.8 K to 3.6 K (-5.76 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.17 | 6 | 349 | 3,801 | 3.8 K to 3.8 K (-0.16 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.16 | 31 | 1,803 | 3,807 | 3.8 K to 3.8 K (-0.81 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.14 | 14 | 814 | 3,838 | 3.9 K to 3.8 K (-0.36 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.12 | 5 | 291 | 3,852 | 3.9 K to 3.9 K (-0.13 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.10 | 70 | 4,067 | 3,857 | 3.9 K to 3.9 K (-1.78 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 57.82 | 12 | 694 | 3,927 | 3.9 K to 3.9 K (-0.30 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 57.81 | 75 | 4,336 | 3,939 | 4 K to 3.9 K (-1.87 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 57.80 | 6 | 347 | 4,014 | 4 K to 4 K (-0.15 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 57.76 | 13 | 751 | 4,020 | 4 K to 4 K (-0.32 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 57.75 | 307 | 17,729 | 4,033 | 4.3 K to 4 K (-7.07 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,450 | 24,379 | 4,340 | 2.9 K to 4.3 K (+50.17 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 7,968 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 30.74 | 9,000 | 276,660 | 55,744 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.61 | 847 | 49,643 | 4,255 | 5.1 K to 4.3 K (-16.60 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.52 | 126 | 7,374 | 5,102 | 5.2 K to 5.1 K (-2.41 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.50 | 974 | 56,979 | 5,228 | 6.2 K to 5.2 K (-15.70 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.33 | 2,392 | 139,525 | 6,202 | 8.6 K to 6.2 K (-27.83 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.24 | 84 | 4,892 | 8,594 | 8.7 K to 8.6 K (-0.97 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.23 | 126 | 7,337 | 8,678 | 8.8 K to 8.7 K (-1.43 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.22 | 84 | 4,890 | 8,804 | 8.9 K to 8.8 K (-0.95 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.21 | 42 | 2,445 | 8,888 | 8.9 K to 8.9 K (-0.47 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.20 | 1,480 | 86,136 | 8,930 | 10.4 K to 8.9 K (-14.22 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.17 | 42 | 2,443 | 10,410 | 10.5 K to 10.4 K (-0.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.16 | 212 | 12,330 | 10,452 | 10.7 K to 10.5 K (-1.99 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.14 | 86 | 5,000 | 10,664 | 10.8 K to 10.7 K (-0.80 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.12 | 43 | 2,499 | 10,750 | 10.8 K to 10.8 K (-0.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.10 | 466 | 27,075 | 10,793 | 11.3 K to 10.8 K (-4.14 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 57.82 | 85 | 4,915 | 11,259 | 11.3 K to 11.3 K (-0.75 %) |